Health Discovery Corp

HDVY OTC
HDVY
Health Discovery Corp OTC
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

HDVY Stock Chart

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Technology Services
Industry: Information Technology Services
Health Discovery Corp. operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. The firm property include Support Vector Machines (SVM), which are mathematical algorithms that allow computers to sift through datasets to identify patterns; recursive feature elimination SVM that identifies and rank orders the data points that contribute the desired results; FGM, which enhances the mapping of genetic pathways involved in the diagnosis and prevention of certain diseases; and biomarkers, which are biological indicators or genetic expression signatures of certain disease states. It also develops a blood test for prostate cancer; and diagnostic test to interpret flow cell cytometry data for myelodysplastic syndrome, as well as provides an image analysis tool for cytogenetic analysis. The company was founded by Stephen D. Barnhill in 2001 and is headquartered in Atlanta, GA.

Breaking news